SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
about
Dietary Phenolic Compounds Interfere with the Fate of Hydrogen Peroxide in Human Adipose Tissue but Do Not Directly Inhibit Primary Amine Oxidase Activity.Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells.Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.A genome-wide scan for circulating vascular adhesion protein-1 (VAP-1) levels: MACROD2 as a potential transcriptional regulator of adipogenesis.Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
P2860
Q36530382-F632A753-1149-4B7C-AC6A-F5C98FD0B71FQ37889987-57224C40-97F2-4B88-BD40-1A5C56AA77E8Q39471261-5317AE31-7B25-4D11-8DED-311F3DC081E7Q42519219-076F431B-C604-4096-9F0E-45E43DFB9C4BQ45995520-E92DBBFC-83B8-4834-87A5-4ACD4C702730Q47647802-F2F7FBFE-2702-4F4E-A101-C62E951CD3C2Q53649555-18F1DCB5-03C8-4987-8FA1-6CF3CBAC6FA9
P2860
SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@en
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@nl
type
label
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@en
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@nl
prefLabel
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@en
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@nl
P2093
P2860
P356
P1476
SSAO substrates exhibiting ins ...... ption for metabolic disorders.
@en
P2093
Agota Földi
Balázs Balogh
Camille Attané
Christian Carpéné
Josep Mercader
Petra Dunkel
Philippe Valet
Péter Mátyus
Xavier Brenachot
Zsuzsa Iffiú-Soltesz
P2860
P304
P356
10.4155/FMC.10.260
P577
2010-12-01T00:00:00Z